Skip to content

Combination of ECMO and CytoSorb hemoadsorption in COVID-19 patients and beyond

Combination of ECMO and CytoSorb hemoadsorption in COVID-19 patients and beyond
Chair: Roberto Lorusso, Maastricht/The Netherlands
Speakers: L. Christian Napp, Hannover/Germany; Alexander Supady, Freiburg/Germany; Nader Moazami, New York/USA; Ali Akil, Ibbenbueren/Germany

Agenda
Rationale for the use of CytoSorb in ECMO patients
L. Christian Napp, Hannover/Germany

Cytokine adsorption in severe COVID-19 pneumonia requiring ECMO – the CYCOV study
Alexander Supady, Freiburg/Germany

First clinical experiences in the USA
Nader Moazami, New York/USA

Reduction of hyperinflammation, septic shock and MOF – we can do it better
Ali Akil, Ibbenbueren/Germany

Play Video

Share

|

Combination of ECMO and CytoSorb hemoadsorption in COVID-19 patients and beyond

Play Video

Share

|

Combination of ECMO and CytoSorb hemoadsorption in COVID-19 patients and beyond
Chair: Roberto Lorusso, Maastricht/The Netherlands
Speakers: L. Christian Napp, Hannover/Germany; Alexander Supady, Freiburg/Germany; Nader Moazami, New York/USA; Ali Akil, Ibbenbueren/Germany

Agenda
Rationale for the use of CytoSorb in ECMO patients
L. Christian Napp, Hannover/Germany

Cytokine adsorption in severe COVID-19 pneumonia requiring ECMO – the CYCOV study
Alexander Supady, Freiburg/Germany

First clinical experiences in the USA
Nader Moazami, New York/USA

Reduction of hyperinflammation, septic shock and MOF – we can do it better
Ali Akil, Ibbenbueren/Germany